SCHEMBL22050366

SCHEMBL22050366

CCCCc1ccc(C(c2ccc(N)cc2)c2ccc(N)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.50
MAOB P27338 3/20 0.48
GFER P55789 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.46
CA2 P00918 2/20 0.46
MAPT P10636 2/20 0.46
SKP2 Q13309 1/20 0.46
CA1 P00915 1/20 0.44
ALDH1A1 P00352 3/20 0.43
HSD17B10 Q99714 3/20 0.43
HPGD P15428 2/20 0.43
RAB9A P51151 2/20 0.42
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 1/20 0.42
USP2 O75604 1/20 0.42
GAA P10253 1/20 0.42
KMT2A Q03164 1/20 0.42
MAOA P21397 1/20 0.42
TP53 P04637 2/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2494565 0.90 CA2 (0.52) HTR2ASMN1; SMN2CA2SKP2CA1
SCHEMBL22050369 0.88 GFER (0.52) HTR2AMAOBGFERCA2MAPT
SCHEMBL111607 0.88 GFER (0.62) HTR2AMAOBGFERSMN1; SMN2CA2
SCHEMBL27497386 0.87 HTR2A (0.48) HTR2AMAOBGFERSMN1; SMN2CA2
Iodide SCHEMBL31425562 0.86 HTR2A (0.59) HTR2AMAOBGFERSMN1; SMN2CA2
Hydrochloric Acid SCHEMBL2857384 0.86 MAOB (0.61) HTR2AMAOBGFERSMN1; SMN2CA2
SCHEMBL27496037 0.84 HTR2A (0.51) HTR2AMAOBGFERSMN1; SMN2CA2
SCHEMBL22346191 0.84 HTR2A (0.69) HTR2AMAOBGFERSMN1; SMN2CA2
SCHEMBL3432822 0.84 HTR2A (0.57) HTR2AMAOBGFERSMN1; SMN2CA2
SCHEMBL27481230 0.82 HTR2A (0.54) HTR2AMAOBGFERSMN1; SMN2CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210003921-A1 COMPOUND, RESIN, COMPOSITION, AND FILM FORMING MATERIAL FOR LITHOGRAPHY USING THE SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-01-07 US disclosed
EP-3760611-A1 COMPOUND, RESIN, COMPOSITION AND FILM-FORMING MATERIAL FOR LITHOGRAPHY USING SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-01-06 EP disclosed
US-20200172470-A1 NOVEL (POLY)AMINE COMPOUND, RESIN AND CURED PRODUCT MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2020-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210003921-A1 COMPOUND, RESIN, COMPOSITION, AND FILM FORMING MATERIAL FOR LITHOGRAPHY USING THE SAME COL1A1, MLLT3, F12 HTR2A 2731/4885MAOB 3439/4885GFER 383/4885
US-20200172470-A1 NOVEL (POLY)AMINE COMPOUND, RESIN AND CURED PRODUCT PAM, CBR1, KDM1A HTR2A 1451/4885MAOB 1003/4885GFER 329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.